Yale School of Public Health doctor: Genomic sequencing will help detect Omicron faster
A Yale School of Public Health doctor says genomic sequencing will help experts identify the omicron variant if or when it make its way to Connecticut.
News 12 Staff
•
Dec 2, 2021, 11:09 AM
•
Updated 869 days ago
Share:
More Stories
Hometown Heroes in Connecticut
2ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
200ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
206ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
212ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
233ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
252ds agoHometown Heroes in Connecticut
2ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
200ds ago0:29
Connecticut health commissioner fired during COVID settles with state; dismissal now a resignation
206ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
212ds ago2:00
Should you get a COVID booster? Hartford Healthcare doctor says wait
233ds ago0:22
Nearly 200 Stamford small businesses to receive COVID-19 relief grants
252ds agoA Yale School of Public Health doctor says genomic sequencing will help experts identify the omicron variant if or when it make its way to Connecticut.
Now that the omicron variant has been detected in the United States, doctors at the Yale School of Medicine are working to figure out how transmissible it is.
The team at the Yale School of Public Health is helping determine which variants are in Connecticut.
Dr. Nathan Grubaugh says the work doctors are doing now will help them to be prepared for the worst.
"When, and if, Omicron is introduced to our region, we can track it and better understand it."
The team is conducting genomic sequencing on PCR tests to figure out which variant a patient has contracted.
Doctors say genome sequencing is conducted on 30% of cases a week.
